About
Laurent Pharmaceuticals is a Montreal-based clinical-stage biotechnology company developing LAU-7b, a small-molecule drug candidate in Phase 2 clinical trials designed to target multiple molecular pathways for degenerative diseases.
Explore Laurent Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.